These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16504823)

  • 1. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents.
    Dooley MA; Ginzler EM
    Rheum Dis Clin North Am; 2006 Feb; 32(1):91-102, ix. PubMed ID: 16504823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus--2005 annus mirabilis?
    Isenberg D; Rahman A
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):145-52. PubMed ID: 16932674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble mediators as therapeutic targets in systemic lupus erythematosus: cytokines, immunoglobulin receptors, and the complement system.
    Kirou KA; Salmon JE; Crow MK
    Rheum Dis Clin North Am; 2006 Feb; 32(1):103-19, ix. PubMed ID: 16504824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer therapeutic approaches for systemic lupus erythematosus.
    Ginzler EM; Dvorkina O
    Rheum Dis Clin North Am; 2005 May; 31(2):315-28. PubMed ID: 15922148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus in children: current and emerging therapies.
    Macdermott EJ; Adams A; Lehman TJ
    Lupus; 2007; 16(8):677-83. PubMed ID: 17711907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trials and tribulations in systemic lupus erythematosus.
    Wofsky D
    Bull NYU Hosp Jt Dis; 2010; 68(3):175-8. PubMed ID: 20969548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.
    Sousa E; Isenberg D
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):563-74. PubMed ID: 19591785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells in SLE: different biological drugs for different pathogenic mechanisms.
    Diamanti AP; Rosado MM; Carsetti R; Valesini G
    Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not!
    Karim MY; Pisoni CN; Khamashta MA
    Rheumatology (Oxford); 2009 Apr; 48(4):332-41. PubMed ID: 19155279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA; McCune WJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticytokine therapy in systemic lupus erythematosus.
    Yoo DH
    Lupus; 2010 Oct; 19(12):1460-7. PubMed ID: 20947558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative management of lupus erythematosus.
    Knott HM; Martínez JD
    Dermatol Clin; 2010 Jul; 28(3):489-99. PubMed ID: 20510759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.
    Sherer Y; Kuechler S; Jose Scali J; Rovensky J; Levy Y; Zandman-Goddard G; Shoenfeld Y
    Isr Med Assoc J; 2008 Jan; 10(1):55-7. PubMed ID: 18300575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus: modern strategies for management: a moving target.
    King JK; Hahn BH
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):971-87. PubMed ID: 18068856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on emerging drug therapies for systemic lupus erythematosus.
    Mok CC
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):53-70. PubMed ID: 20148712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.
    Zandman-Goddard G; Blank M; Shoenfeld Y
    Lupus; 2009 Sep; 18(10):884-8. PubMed ID: 19671787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive therapy in systemic lupus erythematosus.
    Russell AS; Bretscher PA
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():194-8. PubMed ID: 3302253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents.
    Vasquez S; Kavanaugh AF; Schneider NR; Wacholtz MC; Lipsky PE
    J Rheumatol; 1992 Oct; 19(10):1625-7. PubMed ID: 1464880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of systemic lupus erythematosis and myasthenia gravis. A new case report].
    Louzir B; Ben Abdelhafidh N; Bahri M; M'Sadek F; Ksontini I; Boussema E; Othmani S
    Tunis Med; 2003 Dec; 81(12):963-6. PubMed ID: 14986533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New concepts for the therapy of systemic lupus erythematosus].
    Spertini F
    Rev Med Suisse; 2007 Jan; 3(94):98-102. PubMed ID: 17354532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.